Becker Hewes
Förmögenhet: 7 M $ per 2026-08-31
Förmögenhet: 7 M $ per 2026-08-31
Becker Hewes is Chief Medical Officer at Damora Therapeutics, Inc. since 2026.
Formerly, Dr. Hewes was Senior Vice President-Clinical Development at Blueprint Medicines Corp.
from 2020 to 2021, Chief Medical Officer at Repertoire Immune Medicines, Inc. from 2017 to 2020, and Executive Director-Translational Clinical Oncology at Novartis Institutes for Biomedical Research, Inc. from 2013 to 2017.
Education includes undergraduate studies at Vanderbilt University and a doctorate from Georgetown University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-05 | 264 629 ( 0,43 % ) | 7 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-01-05 |
| Företag | Position | Slut |
|---|---|---|
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Teknisk/Vetenskaplig/F&U Direktör | 2020-05-01 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Företagsledare/Principal | 2017-02-01 |
| BLUEPRINT MEDICINES CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Blueprint Medicines Corp.
Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Georgetown University School of Medicine
Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån